Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Joost Wiersinga MD, PhD, MBA

W. Joost Wiersinga MD, PhD, MBA

Professor of Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands

Joost Wiersinga, MD, PhD, MBA, is Professor of Medicine and serves as chair of the Division of Infectious Diseases of Amsterdam UMC. He received his medical training at the University of Amsterdam with additional courses at the Mayo Clinic (Rochester, Minnesota) and the National Institutes of Health (NIH, Bethesda, MD). He combines work in the clinic with education and research.

At the Center for Experimental Molecular Medicine (CEMM), he focuses on the host response against severe bacterial infections, sepsis pneumonia and Covid-19 with a special interest in the gut microbiome and melioidosis. His work has been published in among others JAMA, BMJ, Gut, Cell Host Microbe, Nat Rev Microbiol, Lancet Infect Dis, Intensive Care Med and New England Journal of Medicine.

For his work, Wiersinga received the Andreas Bonn medallion, the ESCMID Young Investigator Award and the ANZICS Global Rising Star Award. Wiersinga chaired the Infection group of the Surviving Sepsis Campaign guidelines, is council member of the International Sepsis Forum (ISF) and immediate past chair of the ESCMID Study Group for Bloodstream Infections, Endocarditis and Sepsis (ESGBIES). He receives grants from the Netherlands Organisation for Health Research and Development (ZonMw, Vidi-grant) and the European Union.

Disclosures

Dr. Wiersinga has no relevant disclosures.